Company Financials

Royalty Pharma plc Financials

United States dollar

business Royalty Pharma plc Company Profile

Main Stock Listing

NASDAQ: RPRX

Market Capitalization $22.66 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 22.08
Forward PE 7.65
Price to Sales TTM $9.59
Price to Book MRQ $2.58
Enterprise to Revenue 11.80
Enterprise to EBITDA 20.27

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 32.55%
Operating Margin 70.27%
Return on Assets TTM 5.22%
Return on Equity TTM 13.10%

Income Statement

Revenue TTM $2,349,843,968
Revenue per Share TTM $5.41
Quarterly Revenue Growth 7.90%
Gross Profit TTM $2,504,751,104
EBITDA $1,617,850,000
Net Income to Common TTM $764,956,032
Diluted EPS TTM $1.75
Quarterly Earnings Growth YoY -47.00%

Balance Sheet

Total Cash MRQ $955,043,968
Total Cash per Share MRQ $2.24
Total Debt MRQ $
Total Debt to Equity MRQ 93.19
Current Ratio MRQ 3.48
Book Value per Share MRQ $14.95

Cash Flow

Operating Cash Flow TTM $2,405,199,872
Levered Free Cash Flow TTM $-590,954,496

RPRX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 429,027,000
Float Shares 375,371,099
Avg 10 Volume 2,666,780
Avg 30 Volume None
Shares Short 27,721,192
Short Ratio 6.11
Short % of Shares 6.59%
% Held by Insiders 8.84%
% Held by Institutions 81.83%

Stock Price Summary

Beta 0.46
Fifty Two Week Low $25.40
Fifty Two Week High $41.24
Fifty Two Week Change 33.74%
Day 50 MA $38.67
Day 200 MA $35.69

Dividends and Splits

Forward Annual Dividend Rate $0.88
Forward Annual Dividend Yield 2.26%
Trailing Annual Dividend Rate $0.88
Trailing Annual Dividend Yield 2.26%
Payout Ratio 49.71%
Dividend Date 2025-12-10
Ex Dividend Date 2025-11-14
Last Split Factor
Last Split Date